業績一覧

ACHIEVEMENT LIST

  • Fujima N, Nakagawa J, Kameda H, Ikebe Y, Harada T, Shimizu Y, Tsushima N, Kano S, Homma A, Kwon J, Yoneyama M, Kudo K: Improvement of image quality in diffusion-weighted imaging with model-based deep learning reconstruction for evaluations of the head and neck

    MAGMA. 37(3): 439-447, 2024

  • Fujima N, Shimizu Y, Ikebe Y, Kameda H, Harada T, Tsushima N, Kano S, Homma A, Kwon J, Yoneyama M, Kudo K: Dual-type deep learning-based image reconstruction for advanced denoising and super-resolution processing in head and neck T2-weighted imaging

    Jpn J Radiol. 43(7): 1097-1105, 2025

  • Yasuda K, Uchinami Y, Kano S, Taguchi J, Kawakita D, Kitayama M, Nishioka K, Mori T, Koizumi F, Fujii Y, Shimizu Y, Kobashi K, Yoshimoto S, Nibu KI, Homma A, Aoyama H: Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan

    Int J Clin Oncol. 29(3): 241-247, 2024

  • Yasuda K, Kiyota N, Matsuura K, Saito S, Honma Y, Imamura Y, Tanaka K, Zenda S, Onoe T, Kodaira T, Kobayashi S, Aoyama H, Hanai N, Homma A: Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group

    Front Oncol. 14: 1441056, 2025

  • Yokoyama K, Wasano K, Sasaki K, Machida R, Nakahira M, Kitamura K, Sakagami T, Takeshita N, Ohkoshi A, Suzuki M, Tateya I, Morishita Y, Sekimizu M, Nakayama M, Koyama T, Shibata H, Miyamaru S, Kiyota N, Hanai N, Homma A: Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck

    Jpn J Clin Oncol. 54(10): 1115-1122, 2024

  • Rao KN, Piazza C, Snyderman C, Vander Poorten V, Sreeram MP, Strojan P, Hanna E, Guntinas-Lichius O, Lopez F, Mikkelsen LH, Suárez C, Homma A, Babighian S, Kowalski LP, Ferlito A: Evidence Based Recommendations in Sinonasal Tumors Involving Orbit: Preservation or Exenteration? An IHNSG Guidelines

    Adv Ther. 42(3): 1312-1339, 2025

  • Lim AM, McDowell L, Hurt C, Tourneau CL, Homma A, Shenouda G, Thomson DJ, Moya-Plana A, Henson C, Szturz P, Day AT, Bates JE, Lazarakis S, Thariat J, Psyrri A, Mehanna H, Yom S, HNCIG: Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations

    Lancet Oncol, 25(7): e318-e330, 2024

  • Rodrigo JP, López-Álvarez F, Medina JE, Silver CE, Robbins KT, Hamoir M, Mäkitie A, de Bree R, Takes RP, Golusinski P, Kowalski LP, Forastiere AA, Homma A, Hanna EY, Rinaldo A, Ferlito A: Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancer

    Eur J Surg Oncol. 50(7): 108389, 2024

  • Lopez F, Agaimy A, Franchi A, Suárez C, Vander Poorten V, Mäkitie AA, Homma A, Eisbruch A, Olsen KD, Saba NF, Nuyts S, Snyderman C, Beitler JJ, Corry J, Hanna E, Hellquist H, Rinaldo A, Ferlito A: Update on olfactory neuroblastoma

    Virchows Arch. 484(4): 567-585, 2024

  • Watanabe S, Hirata K, Magota K, Takenaka J, Wakabayashi N, Shinyama D, Yasuda K, Homma A, Kudo K: Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET

    Ann Nucl Med. 38(2): 131-138, 2024

次ページへ » もっと見る